Next Article in Journal
Preliminary Results of the “Capasquelet” Technique for Managing Femoral Bone Defects—Combining a Masquelet Induced Membrane and Capanna Vascularized Fibula with an Allograft
Next Article in Special Issue
Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
Previous Article in Journal
Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients
Previous Article in Special Issue
Physiotherapy versus Consecutive Physiotherapy and Cognitive Treatment in People with Parkinson’s Disease: A Pilot Randomized Cross-Over Study
 
 
Viewpoint

Article Versions Notes

J. Pers. Med. 2021, 11(8), 773; https://doi.org/10.3390/jpm11080773
Action Date Notes Link
article xml file uploaded 7 August 2021 10:05 CEST Original file -
article xml uploaded. 7 August 2021 10:05 CEST Update -
article pdf uploaded. 7 August 2021 10:05 CEST Version of Record https://www.mdpi.com/2075-4426/11/8/773/pdf-vor
article html file updated 7 August 2021 10:06 CEST Original file -
article xml file uploaded 9 August 2021 13:24 CEST Update -
article xml uploaded. 9 August 2021 13:24 CEST Update -
article pdf uploaded. 9 August 2021 13:24 CEST Updated version of record https://www.mdpi.com/2075-4426/11/8/773/pdf-vor
article html file updated 9 August 2021 13:25 CEST Update -
article xml file uploaded 11 August 2021 03:17 CEST Update -
article xml uploaded. 11 August 2021 03:17 CEST Update https://www.mdpi.com/2075-4426/11/8/773/xml
article pdf uploaded. 11 August 2021 03:17 CEST Updated version of record https://www.mdpi.com/2075-4426/11/8/773/pdf
article html file updated 11 August 2021 03:18 CEST Update -
article html file updated 27 July 2022 08:39 CEST Update https://www.mdpi.com/2075-4426/11/8/773/html
Back to TopTop